Citation Impact
Citing Papers
Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice
2017
Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica
2007
IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum
2010
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary
2014 Standout
Complement-dependent Cytotoxicity in Neuromyelitis Optica Requires Aquaporin-4 Protein Assembly in Orthogonal Arrays
2012
Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial
2014
An integrated map of genetic variation from 1,092 human genomes
2012 StandoutNature
Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo
2009
Combining population genomics and quantitative genetics: finding the genes underlying ecologically important traits
2007
MRI and the diagnosis of multiple sclerosis: expanding the concept of “no better explanation”
2006
Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms
2022
Myasthenia Gravis
2016 Standout
Defining the Role of the MHC in Autoimmunity: A Review and Pooled Analysis
2008
European Ancestry as a Risk Factor for Atrial Fibrillation in African Americans
2010
The spectrum of neuromyelitis optica
2007 Standout
Neuromyelitis Optica
2010
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
2010 Standout
The microbiota in adaptive immune homeostasis and disease
2016 StandoutNature
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
2006 Standout
T Cell-Mediated Autoimmune Disease Due to Low-Affinity Crossreactivity to Common Microbial Peptides
2009
Interleukin-10-Producing Plasmablasts Exert Regulatory Function in Autoimmune Inflammation
2014 StandoutNobel
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
2011 StandoutNature
Serum anti-GAGA4 IgM antibodies differentiate relapsing remitting and secondary progressive multiple sclerosis from primary progressive multiple sclerosis and other neurological diseases
2009
Hallmarks of aging: An expanding universe
2023 Standout
Serum 25-Hydroxyvitamin D Levels and Risk of Multiple Sclerosis
2006
Pediatric Multiple Sclerosis
2010
Vitamin D Deficiency
2007 Standout
Neuromyelitis Optica and Non–Organ-Specific Autoimmunity
2008
Psoriasis
2021 Standout
Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives
1997
Pediatric Multiple Sclerosis
2011
Inflammatory Bowel Disease
2009 Standout
MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process
2015
Revised diagnostic criteria for neuromyelitis optica (NMO)
2007
The challenge of multiple sclerosis: How do we cure a chronic heterogeneous disease?
2009
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
2008 Standout
Neuromyelitis optica
2005
Update on PML and PML-IRIS Occurring in Multiple Sclerosis Patients Treated With Natalizumab
2012
Multiple sclerosis
2008 Standout
Structural and functional features of central nervous system lymphatic vessels
2015 StandoutNature
Speciation through sensory drive in cichlid fish
2008 StandoutNature
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Global cancer statistics
2011 Standout
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis
2017
Interleukin-17 and Type 17 Helper T Cells
2009 Standout
Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis
2005
The epidemiology of multiple sclerosis
2016
Methods for High-Density Admixture Mapping of Disease Genes
2004
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Glia Disease and Repair—Remyelination
2015
Drainage of Cells and Soluble Antigen from the CNS to Regional Lymph Nodes
2013
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
2018 Standout
Sex differences in autoimmune diseases
2011
Glial degeneration and reactive gliosis in alpha-synucleinopathies: the emerging concept of primary gliodegeneration
2006
Population Genomics and the Statistical Values of Race: An Interdisciplinary Perspective on the Biological Classification of Human Populations and Implications for Clinical Genetic Epidemiological Research
2016
Uric acid in multiple sclerosis
2006
The immunology of stroke: from mechanisms to translation
2011 Standout
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Sickle-cell disease
2010 Standout
Revised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple Sclerosis
2015
Axonal Transection in the Lesions of Multiple Sclerosis
1998 Standout
Results from a prostate cancer admixture mapping study in African-American men
2009
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
2011 Standout
Seizure‐Promoting Effect of Blood–Brain Barrier Disruption
2007
Defining Disease Activity and Response to Therapy in MS
2017
Tryptophan degradation in autoimmune diseases
2007
Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
2012 Standout
Neurological autoimmunity targeting aquaporin-4
2009
Multiple Sclerosis
2000 Standout
Neuromyelitis optica spectrum disorders associated with other autoimmune diseases
2014
Natalizumab for Multiple Sclerosis
2007
Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years
2008
Sex differences in immune responses
2016 Standout
Outdoor air pollution and asthma
2014 Standout
The Neurobiology of Multiple Sclerosis: Genes, Inflammation, and Neurodegeneration
2006
Myeloid cells — targets of medication in multiple sclerosis
2016
Brain Abnormalities in Neuromyelitis Optica
2006
Estimating Local Ancestry in Admixed Populations
2008
Inflammasomes: mechanism of action, role in disease, and therapeutics
2015 Standout
A Systematic Review of Pharmacological Pain Management in Multiple Sclerosis
2013
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
2004 Standout
B Cells in the Multiple Sclerosis Central Nervous System: Trafficking and Contribution to CNS-Compartmentalized Inflammation
2015
The gut microbiome as a modulator of healthy ageing
2022
Effector Functions of Antiaquaporin‐4 Autoantibodies in Neuromyelitis Optica
2009
Spinal cord MRI in multiple sclerosis—diagnostic, prognostic and clinical value
2015
From genes to function: the next challenge to understanding multiple sclerosis
2009
B lineage cells in the inflammatory central nervous system environment: Migration, maintenance, local antibody production, and therapeutic modulation
2006
Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic Disease)
2006
Fast model-based estimation of ancestry in unrelated individuals
2009 Standout
An Overview of the Advantages of KEAP1-NRF2 System Activation During Inflammatory Disease Treatment
2017
Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis
2013
Risikostratifizierung einer progressiven multifokalen Leukenzephalopathie unter Natalizumab
2011
Revised diagnostic criteria for neuromyelitis optica
2006 Standout
Genome-wide patterns of population structure and admixture in West Africans and African Americans
2009
Distinct Effector Cytokine Profiles of Memory and Naive Human B Cell Subsets and Implication in Multiple Sclerosis
2007
Multiple Sclerosis
2018 Standout
Anti-Glycan Antibodies as Biomarkers for Diagnosis and Prognosis
2006
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
2015 Standout
Neuromyelitis Optica Brain Lesions Localized at Sites of High Aquaporin 4 Expression
2006
Confirmation of an Association Between the TNF(−308) Promoter Polymorphism and Stroke Risk in Children With Sickle Cell Anemia
2007
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Worldwide Epidemiology of Atrial Fibrillation
2013 Standout
Atacicept: targeting B cells in multiple sclerosis
2010
A review of the current use of rituximab in autoimmune diseases
2008
Hidden in Plain Sight — Reconsidering the Use of Race Correction in Clinical Algorithms
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Microbiome–microglia connections via the gut–brain axis
2018
Cannabinoids for Medical Use
2015 Standout
Devic’s neuromyelitis optica: a critical review
2008
A review of the mechanisms of action of dimethylfumarate in the treatment of psoriasis
2018
NMO-IgG and Devic's neuromyelitis optica: a French experience
2008
Redox Signaling by Reactive Electrophiles and Oxidants
2018
Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
2008
Parental Smoking Modifies the Relation between Genetic Variation in Tumor Necrosis Factor-α ( TNF ) and Childhood Asthma
2007
Immunosuppressive therapy is more effective than interferon in neuromyelitis optica
2007
Works of Bruce Cree being referenced
Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models
2017
Treatment of Neuromyelitis Optica With Rituximab
2008
Uncoupling the Roles of HLA-DRB1 and HLA-DRB5 Genes in Multiple Sclerosis
2008
Spinal cord gray matter atrophy correlates with multiple sclerosis disability
2014
Baseline Subgroup Characteristics of EXPAND: A Phase 3 Study of Siponimod (BAF312) for the Treatment of Secondary Progressive Multiple Sclerosis (P3.084)
2016
Linkage and association with the NOS2A locus on chromosome 17q11 in multiple sclerosis
2004
Unusual variants of Alexander's disease
2005
Pilot trial of low‐dose naltrexone and quality of life in multiple sclerosis
2010
Mapping Multiple Sclerosis Susceptibility to the HLA-DR Locus in African Americans
2004
Natalizumab dosage suspension: Are we helping or hurting?
2010
Treatment of Multiple Sclerosis: A Review
2020
Quantification and Functional Characterization of Antibodies to Native Aquaporin 4 in Neuromyelitis Optica
2010
B cell exchange across the blood-brain barrier in multiple sclerosis
2012
Neuromyelitis optica: Diagnosis, pathogenesis, and treatment
2008
Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease
2005
Neuromyelitis Optica
2002
Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial
2016
Genetics of primary progressive multiple sclerosis
2014
Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis
2006
A whole-genome admixture scan finds a candidate locus for multiple sclerosis susceptibility
2005
Therapeutic Considerations for Disease Progression in Multiple Sclerosis
2005
Characterizing the Mechanisms of Progression in Multiple Sclerosis
2005
Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis
2005
An open label study of the effects of rituximab in neuromyelitis optica
2005
Siponimod (BAF312) for the treatment of secondary progressive multiple sclerosis: Design of the phase 3 EXPAND trial
2014
Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome
2011
Reduction of CD8 + T lymphocytes in multiple sclerosis patients treated with dimethyl fumarate
2015
Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2
2016
Inclusion of brain volume loss in a revised measure of ‘no evidence of disease activity’ (NEDA-4) in relapsing–remitting multiple sclerosis
2016
Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis
2004
Identification of new serum autoantibodies in neuromyelitis optica using protein microarrays
2006
Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis
2008
Emerging Monoclonal Antibody Therapies for Multiple Sclerosis
2006